Raymond James Starts Nivalis Therapeutics (NVLS) at Outperform

September 13, 2016 6:51 AM EDT
Get Alerts NVLS Hot Sheet
Price: $2.24 --0%

Rating Summary:
    1 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 32 | New: 34
Trade NVLS Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Raymond James initiated coverage on Nivalis Therapeutics (NASDAQ: NVLS) with an Outperform rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Nivalis Therapeutics click here. For more ratings news on Nivalis Therapeutics click here.

Shares of Nivalis Therapeutics closed at $7.77 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot New Coverage, New Coverage

Related Entities

Raymond James

Add Your Comment